Increased Iron Levels and Decreased Tissue Integrity in Hippocampus of Alzheimer’s Disease Detected in vivo with Magnetic Resonance Imaging
Abstract
BACKGROUND: Iron can catalyze damaging free radical reactions. With age, iron accumulates in brain gray matter regions and may contribute to the risk of developing age-related diseases such as Alzheimer's disease (AD). Prior MRI studies demonstrated increased iron deposits in basal ganglia regions; however, the hippocampus (Hipp), which is heavily damaged in AD, and comparator regions that are resistant to AD damage, such as thalamus (Th), have rarely been examined. OBJECTIVE: To assess iron levels and evidence of tissue damage in Hipp and Th of AD subjects and healthy controls. METHODS: Thirty-one AD and sixty-eight healthy control subjects participated in this study. High- and low-field strength MRI instruments were used in combination to quantify iron content of ferritin molecules (ferritin iron) using the field dependent relaxation rate increase (FDRI) method. Decreased transverse relaxation rate (R2) was used as an index of tissue damage. RESULTS: Compared with healthy controls, AD subjects had increased ferritin iron in Hipp (p = 0.019) but not Th (p = 0.637), and significantly decreased R2 in Hipp (p < 0.001) but not Th (p = 0.37). In the entire sample, FDRI and R2 were negatively correlated. CONCLUSION: The data shows that in AD, Hipp damage occurs in conjunction with ferritin iron accumulation. Prospective studies are needed to evaluate how increasing iron levels may influence the trajectory of tissue damage and cognitive and pathologic manifestations of AD.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Abnormal iron deposition observed in hippocampus, cortex, and basal ganglia of AD patients supports its pathogenic role, with neuroimaging highlighting iron as a biomarker of disease burden.
“Abnormal iron deposition observed in the hippocampus, cortex, and basal ganglia of AD patients further supports its pathogenic role, with neuroimaging studies increasingly highlighting iron as a biomarker of disease burden [109].”
From Toward a Unified Framework in Molecular Neurobiology of Alzheimer’s Disease: Revisiting the Pathophysiological Hypotheses (2026) · cites this paper as [109]
Iron levels in the hippocampus of Alzheimer's disease patients are significantly elevated.
“Iron levels in the hippocampus of AD patients, are significantly elevated [97].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [97]
The citation lists haven’t been fetched yet
References 103 · Cited by 270
- Authors
- Raven, E. P., Lu, P. H., Tishler, T. A., Heydari, P., & Bartzokis, G.
- Affiliations
- University of California, Los Angeles (US)
- Corresponding author
- Bartzokis, George
- Venue
- Journal of Alzheimer s Disease
- Publisher
- SAGE Publications
- Published
- 2013-08-20
- Volume
- 37
- Issue
- 1
- Pages
- 127-136
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1561232794
- Cited by
- 270
- References
- 103
- Citations by year
- 2026: 20 · 2025: 24 · 2024: 21 · 2023: 26 · 2022: 26 · 2021: 24 · 2020: 21 · 2019: 15 · 2018: 20 · 2017: 18 · 2016: 16 · 2015: 20 · 2014: 12 · 2013: 7
- FWCI
- 14.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (R01AG027342, AG027342)
- National Institute of Mental Health (MH0266029)
- National Institute of Neurological Disorders and Stroke (T32NS041231)
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- Alzheimer's disease, hippocampus
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Female, Ferritins, Hippocampus, Humans, Iron, Magnetic Resonance Imaging, Male, Middle Aged
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review